Intuitive Surgical (NASDAQ:ISRG) Stock Price Down 0.4% on Insider Selling

Intuitive Surgical, Inc. (NASDAQ:ISRG)’s stock price traded down 0.4% during trading on Tuesday after an insider sold shares in the company. The company traded as low as $563.85 and last traded at $571.10. 572,352 shares changed hands during trading, a decline of 70% from the average session volume of 1,933,652 shares. The stock had previously closed at $573.48.

Specifically, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Analysts Set New Price Targets

Several analysts have commented on the stock. JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. BTIG Research boosted their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Evercore ISI raised their target price on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday. Finally, The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Stock Up 1.3 %

The stock has a 50-day moving average price of $549.32 and a 200 day moving average price of $507.50. The firm has a market capitalization of $206.65 billion, a price-to-earnings ratio of 93.28, a P/E/G ratio of 5.19 and a beta of 1.39.

Institutional Investors Weigh In On Intuitive Surgical

A number of large investors have recently modified their holdings of the company. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth approximately $26,000. Godsey & Gibb Inc. raised its holdings in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical during the 3rd quarter worth $33,000. Decker Retirement Planning Inc. purchased a new position in Intuitive Surgical in the fourth quarter worth $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $38,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.